S&P 500   2,986.20 (-0.39%)
DOW   26,770.20 (-0.95%)
QQQ   191.69 (-0.96%)
AAPL   236.41 (+0.48%)
FB   185.85 (-2.38%)
MSFT   137.41 (-1.63%)
GOOGL   1,244.41 (-0.67%)
AMZN   1,757.51 (-1.68%)
CGC   20.21 (-2.65%)
NVDA   190.49 (-1.96%)
MU   43.47 (-4.46%)
BABA   169.13 (-4.37%)
GE   8.96 (-0.88%)
TSLA   256.95 (-1.92%)
AMD   30.97 (-0.55%)
T   38.47 (+1.75%)
F   9.29 (+1.98%)
ACB   3.68 (-5.40%)
PRI   123.53 (-0.44%)
NFLX   275.30 (-6.15%)
BAC   30.35 (+0.30%)
GILD   64.91 (-0.49%)
DIS   130.89 (-1.12%)
S&P 500   2,986.20 (-0.39%)
DOW   26,770.20 (-0.95%)
QQQ   191.69 (-0.96%)
AAPL   236.41 (+0.48%)
FB   185.85 (-2.38%)
MSFT   137.41 (-1.63%)
GOOGL   1,244.41 (-0.67%)
AMZN   1,757.51 (-1.68%)
CGC   20.21 (-2.65%)
NVDA   190.49 (-1.96%)
MU   43.47 (-4.46%)
BABA   169.13 (-4.37%)
GE   8.96 (-0.88%)
TSLA   256.95 (-1.92%)
AMD   30.97 (-0.55%)
T   38.47 (+1.75%)
F   9.29 (+1.98%)
ACB   3.68 (-5.40%)
PRI   123.53 (-0.44%)
NFLX   275.30 (-6.15%)
BAC   30.35 (+0.30%)
GILD   64.91 (-0.49%)
DIS   130.89 (-1.12%)
Log in

NGM Biopharmaceuticals Price Target & Analyst Ratings (NYSE:NGM)

$11.17
+0.30 (+2.76 %)
(As of 10/18/2019 04:00 PM ET)
Add
Today's Range
$10.77
Now: $11.17
$11.44
50-Day Range
$10.11
MA: $14.52
$18.19
52-Week Range
$8.81
Now: $11.17
$19.27
Volume277,050 shs
Average Volume108,456 shs
Market Capitalization$737.70 million
P/E RatioN/A
Dividend YieldN/A
BetaN/A

Analyst Ratings

NGM Biopharmaceuticals (NYSE:NGM) Price Target and Consensus Rating

  (How are Consensus Ratings Calculated?)
5 Wall Street analysts have issued ratings and price targets for NGM Biopharmaceuticals in the last 12 months. Their average twelve-month price target is $25.20, suggesting that the stock has a possible upside of 125.60%. The high price target for NGM is $29.00 and the low price target for NGM is $22.00. There are currently 5 buy ratings for the stock, resulting in a consensus rating of "Buy."
Today30 Days Ago90 Days Ago180 Days Ago
Consensus Rating: BuyBuyBuyN/A
Consensus Rating Score: 3.003.003.00N/A
Ratings Breakdown: 0 Sell Rating(s)
0 Hold Rating(s)
5 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
0 Hold Rating(s)
4 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
0 Hold Rating(s)
4 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
0 Hold Rating(s)
0 Buy Rating(s)
0 Strong Buy Rating(s)
Consensus Price Target: $25.20$25.50$25.50N/A
Price Target Upside: 125.60% upside70.80% upside84.12% upsideN/A

NGM Biopharmaceuticals (NYSE:NGM) Consensus Price Target History

NGM Biopharmaceuticals (NYSE:NGM) Analyst Ratings History

Show:
DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
10/17/2019B. RileyInitiated CoverageBuy$24.00High
8/14/2019Stifel NicolausReiterated RatingBuy$26.00Low
5/20/2019CowenReiterated RatingBuy$25.00Medium
4/29/2019CitigroupInitiated CoverageBuy ➝ Buy$29.00High
4/29/2019Goldman Sachs GroupInitiated CoverageBuy ➝ Buy$22.00Medium
(Data available from 10/18/2017 forward)
This page was last updated on 10/18/2019 by MarketBeat.com Staff

Featured Article: Net Margin

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel